Please assess the completion status of the following clinical trial:

Trial Title: A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Cytokine refractory metastatic renal cell carcinoma with clear cell component~* Radiographic evidence of disease progression during or within 9 months of completion of 1 cytokine therapy~* Prior nephrectomy~Exclusion Criteria:~* Prior treatment with any systemic therapy other than 1 cytokine therapy~* History of or known brain metastases~* Uncontrolled hypertension or other significant cardiac events within the 12 months prior to study start

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).